Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients

[1]  Borghi Claudio,et al.  Pulmonary Embolism in Patients with COVID-19 , 2022, Clinical Cardiology and Cardiovascular Interventions.

[2]  R. Favory,et al.  Pulmonary Embolism in Patients With COVID-19 , 2020, Circulation.

[3]  David M. Evans,et al.  Plasma Cortisol, Aldosterone, and Ascorbic Acid Concentrations in Patients with Septic Shock do not Predict Treatment Effect of Hydrocortisone on Mortality: A Nested Cohort Study. , 2020, American journal of respiratory and critical care medicine.

[4]  F. Rieux-Laucat,et al.  Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients , 2020, medRxiv.

[5]  A. Rauch,et al.  Pulmonary Embolism in COVID-19 Patients: Awareness of an Increased Prevalence , 2020 .

[6]  Ş. Balta.  Endothelial dysfunction and inflammatory markers of vascular disease. , 2020, Current vascular pharmacology.

[7]  Holger Moch,et al.  Endothelial cell infection and endotheliitis in COVID-19 , 2020, The Lancet.

[8]  G. Grasselli,et al.  Potential for Lung Recruitment and Ventilation-Perfusion Mismatch in Patients With the Acute Respiratory Distress Syndrome From Coronavirus Disease 2019* , 2020, Critical care medicine.

[9]  Martin Stahl,et al.  Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2 , 2020, Cell.

[10]  J. Q. Brown,et al.  Pulmonary and Cardiac Pathology in Covid-19: The First Autopsy Series from New Orleans , 2020, medRxiv.

[11]  Catherine Beigelman-Aubry,et al.  Vascular Changes Detected With Thoracic CT in Coronavirus Disease (COVID-19) Might Be Significant Determinants for Accurate Diagnosis and Optimal Patient Management. , 2020, AJR. American journal of roentgenology.

[12]  B. Lämmle,et al.  Thrombo-Inflammation in Cardiovascular Disease: An Expert Consensus Document from the Third Maastricht Consensus Conference on Thrombosis , 2020, Thrombosis and Haemostasis.

[13]  Yimin Li,et al.  Ventilatory Ratio in Hypercapnic Mechanically Ventilated Patients with COVID-19–associated Acute Respiratory Distress Syndrome , 2020, American journal of respiratory and critical care medicine.

[14]  Lei Dong,et al.  Kidney disease is associated with in-hospital death of patients with COVID-19 , 2020, Kidney International.

[15]  Carlos Dobkin,et al.  Effect of Influenza Vaccination for the Elderly on Hospitalization and Mortality , 2020, Annals of Internal Medicine.

[16]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[17]  Dengju Li,et al.  Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia , 2020, Journal of Thrombosis and Haemostasis.

[18]  Fengyuan Li,et al.  Circulating angiopoietin-2 and the risk of mortality in patients with acute respiratory distress syndrome: a systematic review and meta-analysis of 10 prospective cohort studies , 2020, Therapeutic advances in respiratory disease.

[19]  G. Iervasi,et al.  Angiopoietin 2 signal complexity in cardiovascular disease and cancer. , 2019, Life sciences.

[20]  A. Garg,et al.  The Association of Angiogenesis Markers With Acute Kidney Injury and Mortality After Cardiac Surgery. , 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  Yaiza Beatriz Molero-Díez,et al.  Fourth universal definition of myocardial infarction , 2019, Colombian Journal of Anesthesiology.

[22]  Jeroen J. Bax,et al.  Fourth Universal Definition of Myocardial Infarction (2018). , 2018, Circulation.

[23]  Jeroen J. Bax,et al.  Fourth universal definition of myocardial infarction (2018). , 2018, European heart journal.

[24]  D. Hoppensteadt,et al.  Angiopoietin 2 Levels in the Risk Stratification and Mortality Outcome Prediction of Sepsis-Associated Coagulopathy , 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[25]  J. Chen,et al.  The association of angiogenic factors and chronic kidney disease , 2018, BMC Nephrology.

[26]  R. Sackstein,et al.  E-Selectin Ligands in the Human Mononuclear Phagocyte System: Implications for Infection, Inflammation, and Immunotherapy , 2018, Front. Immunol..

[27]  F. Blanco,et al.  Human endoglin as a potential new partner involved in platelet–endothelium interactions , 2017, Cellular and Molecular Life Sciences.

[28]  Misha L. Dunbar,et al.  E-selectin inhibition with GMI-1271 decreases venous thrombosis without profoundly affecting tail vein bleeding in a mouse model , 2017, Thrombosis and Haemostasis.

[29]  A. Chauhan,et al.  Endothelial Cell–Derived von Willebrand Factor Is the Major Determinant That Mediates von Willebrand Factor–Dependent Acute Ischemic Stroke by Promoting Postischemic Thrombo-Inflammation , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[30]  J. Mulliken,et al.  E-selectin mediates stem cell adhesion and formation of blood vessels in a murine model of infantile hemangioma. , 2012, The American journal of pathology.

[31]  Fred S Apple,et al.  Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. , 2012, Clinical chemistry.

[32]  G. Krikun,et al.  Preeclampsia, Hypoxia, Thrombosis, and Inflammation , 2011, Journal of pregnancy.

[33]  M. Vidaud,et al.  The angiopoietin pathway is modulated by PAR‐1 activation on human endothelial progenitor cells , 2006, Journal of thrombosis and haemostasis : JTH.

[34]  D. Diz,et al.  Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2 , 2005, Circulation.

[35]  Paul C. Lee,et al.  Endothelial dysfunction in patients with heart failure: relationship to disease severity. , 2000, Journal of cardiac failure.

[36]  C. Sessler,et al.  Soluble E-selectin levels in sepsis and critical illness. Correlation with infection and hemodynamic dysfunction. , 1997, American journal of respiratory and critical care medicine.

[37]  D. Albert.  Suppression of mouse killing by lateral hypothalamic infusion of atropine sulfate in the rat: A general behavioral suppression , 1980, Pharmacology Biochemistry and Behavior.

[38]  Pascal Leprince,et al.  A bioprosthetic total artificial heart for end-stage heart failure: Results from a pilot study. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[39]  K. Hajian‐Tilaki,et al.  Receiver Operating Characteristic (ROC) Curve Analysis for Medical Diagnostic Test Evaluation. , 2013, Caspian journal of internal medicine.

[40]  M. Sjöström,et al.  Fine structural details of human muscle fibres after fibre type specific glycogen depletion , 2004, Histochemistry.